Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis

بواسطة Zhu, Viola W., Zhao, Joseph J., Gao, Yanfei, Syn, Nicholas L., Zhang, Shannon S., Ou, Sai-Hong Ignatius, Bauer, Kenneth A., Nagasaka, Misako
منشور في 2022

Subcutaneous amivantamab and lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Results from the phase 2 PALOMA-2...

بواسطة Lim, Sun Min, Tan, Jiunn-Liang, Dias, Josiane Mourao, Voon, Pei Jye, How, Soon Hin, Zhou, Xiangdong, Xiong, Hailin, Massuti, Bartomeu, Medley, Louise C., Nagasaka, Misako, Vicente, David, Girard, Nicolas, Rittmeyer, Achim, Botesteanu, Dana-Adriana, Alhadab, Ali, Mahoney, Janine M., Zhang, Jie, Bauml, Joshua Michael, Baig, Mahadi, Scott, Susan Combs
منشور في 2024